Redmile Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-428,473
Closed -$22.1M 93
2018
Q3
$22.1M Sell
428,473
-553,200
-56% -$27.1M 0.68% 50
2018
Q2
$46M Sell
981,673
-544,431
-36% -$22.5M 1.56% 23
2018
Q1
$54.2M Buy
1,526,104
+458,786
+43% +$18M 2.09% 17
2017
Q4
$46.5M Buy
1,067,318
+799,400
+298% +$37.3M 2.02% 18
2017
Q3
$14M Sell
267,918
-573,500
-68% -$32M 0.69% 40
2017
Q2
$49.2M Buy
841,418
+207,639
+33% +$10.8M 3% 8
2017
Q1
$29.1M Buy
+633,779
New +$31.5M 1.89% 19

Other funds holding SYNH

Redmile Group's SYNH Position: Q4 2018 in Review

Redmile Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2018, closing a stake of 428,473 shares — an estimated $22.1M sold.

Redmile Group first reported a position in SYNH in Q1 2017 and held it in 7 quarters. The position peaked at $54.2M in Q1 2018. 257 funds tracked by Wall St. Rank hold SYNH as of Q4 2018.

  • Redmile Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2018 after selling out during the quarter.
  • Redmile Group sold 428,473 Syneos Health, Inc. Class A Common Stock shares in Q4 2018, an estimated $22.1M.
  • Redmile Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 7 quarters.
  • Redmile Group's Syneos Health, Inc. Class A Common Stock position peaked at $54.2M in Q1 2018.
  • 257 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2018.

Based on Redmile Group's 13F filing for Q4 2018, filed 14 Feb 2019.